Nephrolithiasis As a Risk Factor of Chronic Kidney Disease: a Meta-analysis of Cohort Studies with 4,770,691 Participants

Overview

Journal Urolithiasis

Publisher Springer

Specialty Urology

Date 2016 Nov 13

PMID 27837248

Citations 34

Authors

Meng Zhe

Zheng Hang

Affiliations

Soon will be listed here.

Abstract

The objective of the study was to investigate the association between nephrolithiasis and the risk of chronic kidney disease (CKD). PubMed, Embase and ScienceDirect databases were searched for relevant cohort studies. A meta-analysis was conducted by pooling data from these studies via an inverse variance method. The Q statistic and I were used to measure heterogeneity. Sensitivity analysis was conducted to ascertain whether the results were stable. Nine studies with eight cohorts involving 4,770,691 participants were identified. Compared to individuals without a history of nephrolithiasis, the pooled relative risk was 1.52 [95% confidence interval (CI) 1.24, 1.68; I = 93.7%] for all stages of CKD and 2.16 (95% CI 1.83-2.54; I = 0.00%) for end-stage kidney disease. Publication bias was not detected. Sensitivity analysis indicated that the results were stable. Nephrolithiasis may increase the risk of CKD, regardless of the patient population (region), and may be an important risk factor for end-stage kidney disease.

Citing Articles

Small Diameter (7.5 Fr) Single-Use Flexible Ureteroscopy with Direct In-Scope Suction (DISS) in Conjunction with Aspiration-Assisted Flexible Access Sheath: A New Hype for Real Stone-Free?.

Geavlete P, Mares C, Multescu R, Georgescu D, Ene C, Iordache V J Clin Med. 2024; 13(23).

PMID: 39685650 PMC: 11642066. DOI: 10.3390/jcm13237191.

Characteristics and Yield of Modern Approaches for the Diagnosis of Genetic Causes of Kidney Stone Disease.

Spasiano A, Treccani M, De Tomi E, Malerba G, Gambaro G, Ferraro P Genes (Basel). 2024; 15(11).

PMID: 39596670 PMC: 11593538. DOI: 10.3390/genes15111470.

The immune factors have complex causal regulation effects on kidney stone disease: a mendelian randomization study.

Yuan D, Yang J, Wu W, Amier Y, Li X, Wan W BMC Immunol. 2024; 25(1):34.

PMID: 38877395 PMC: 11177369. DOI: 10.1186/s12865-024-00627-x.

Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study.

Yuan D, Yang J, Wu W, Amier Y, Li X, Wan W Int Urol Nephrol. 2024; 56(10):3249-3257.

PMID: 38776057 DOI: 10.1007/s11255-024-04084-8.

Review of childhood genetic nephrolithiasis and nephrocalcinosis.

Gefen A, Zaritsky J Front Genet. 2024; 15:1381174.

PMID: 38606357 PMC: 11007102. DOI: 10.3389/fgene.2024.1381174.

References

DCosta M, Savcic-Kos R, Huang J, Rule A, Murali N . Urological Procedures in Urolithiasis and Their Association with Chronic Kidney Disease. Clin Med Res. 2016; 14(2):75-82. PMC: 5321290. DOI: 10.3121/cmr.2016.1261. View

Cheungpasitporn W, Thongprayoon C, Mao M, OCorragain O, Edmonds P, Erickson S . The Risk of Coronary Heart Disease in Patients with Kidney Stones: A Systematic Review and Meta-analysis. N Am J Med Sci. 2014; 6(11):580-5. PMC: 4264294. DOI: 10.4103/1947-2714.145477. View

. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

El-Zoghby Z, Lieske J, Foley R, Bergstralh E, Li X, Melton 3rd L . Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012; 7(9):1409-15. PMC: 3430957. DOI: 10.2215/CJN.03210312. View

Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M . EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2015; 69(3):475-82. DOI: 10.1016/j.eururo.2015.07.041. View

Bekkering G, Harris R, Thomas S, Mayer A, Beynon R, Ness A . How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?. Am J Epidemiol. 2008; 167(9):1017-26. DOI: 10.1093/aje/kwn005. View

Marangella M, Bruno M, Cosseddu D, Manganaro M, Tricerri A, Vitale C . Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron. 1990; 54(4):302-6. DOI: 10.1159/000185884. View

Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M . EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2015; 69(3):468-74. DOI: 10.1016/j.eururo.2015.07.040. View

Hippisley-Cox J, Coupland C . Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract. 2010; 11:49. PMC: 2905345. DOI: 10.1186/1471-2296-11-49. View

10.

Alexander R, Hemmelgarn B, Wiebe N, Bello A, Morgan C, Samuel S . Kidney stones and kidney function loss: a cohort study. BMJ. 2012; 345:e5287. PMC: 3431443. DOI: 10.1136/bmj.e5287. View

11.

Shoag J, Halpern J, Goldfarb D, Eisner B . Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol. 2014; 192(5):1440-5. DOI: 10.1016/j.juro.2014.05.117. View

12.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

13.

Aune D, Lau R, Chan D, Vieira R, Greenwood D, Kampman E . Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology. 2011; 141(1):106-18. DOI: 10.1053/j.gastro.2011.04.013. View

14.

Lieske J, Pena de la Vega L, Slezak J, Bergstralh E, Leibson C, Ho K . Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int. 2006; 69(4):760-4. DOI: 10.1038/sj.ki.5000150. View

15.

Keller J, Chen Y, Lin H . Association between chronic kidney disease and urinary calculus by stone location: a population-based study. BJU Int. 2012; 110(11 Pt C):E1074-8. DOI: 10.1111/j.1464-410X.2012.11380.x. View

16.

Vupputuri S, Soucie J, McClellan W, Sandler D . History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol. 2004; 14(3):222-8. DOI: 10.1016/S1047-2797(03)00126-1. View

17.

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

18.

Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J . Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012; 379(9818):815-22. DOI: 10.1016/S0140-6736(12)60033-6. View

19.

Pearle M, Goldfarb D, Assimos D, Curhan G, Denu-Ciocca C, Matlaga B . Medical management of kidney stones: AUA guideline. J Urol. 2014; 192(2):316-24. DOI: 10.1016/j.juro.2014.05.006. View

20.

Rule A, Bergstralh E, Melton 3rd L, Li X, Weaver A, Lieske J . Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4(4):804-11. PMC: 2666438. DOI: 10.2215/CJN.05811108. View